Back to Results

Myomo Inc (MYO)

Myomo, Inc. is a healthcare equipment and supplies company focused on wearable medical robotics. The company develops and manufactures myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and other international markets. Its product line includes MyoPro, a myoelectric-controlled upper limb brace designed to support a weak or paralyzed arm and assist daily activities, along with MyoPro 2, which adds control technology, configuration software, a user interface, and a pop-out battery for longer use. Myomo also offers MyoPro2+, MyoGames, and the MyoPro 2x Video Library, as well as MyoCare, a post-delivery support program for clients, therapists, and referral sources. The company serves adults and adolescents with conditions related to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. Founded in 2004, Myomo is headquartered in Burlington, Massachusetts, and its common stock trades on the NYSE under the symbol MYO.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-MYO
$1.46
23.0% Upside
Undervalued
$4.64
289.9% Upside
Bargain
Fair
0.0%
8.1x
1.1x
47.133 M
53.762 M
28.1%
70.1%
-3.6
57.4%
Valuation • Fair Value

Myomo Inc (NYSE-MYO) Fair Value by Valuation Model

Review the available estimates for Myomo Inc (NYSE-MYO), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.46

Estimated upside of 23.0% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.81

Discounted cash flow valuation reference.

EPV Fair Value

$1.25

Earnings power value estimate.

Comps Fair Value

$1.38

Comparable-company valuation reference.

Analyst Price Target

$4.64

Analysts imply upside of 289.9%.

How to read these valuation models

Use the 6 available valuation references for Myomo Inc (NYSE-MYO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Myomo Inc (NYSE-MYO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

43.262 M

Current operating scale indicator.

Revenue Forecast

46 M

Forward revenue estimate.

EBITDA

-10.517 M

Current operating profitability reference.

EBITDA Forecast

-5.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Myomo Inc (NYSE-MYO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Myomo Inc (NYSE-MYO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.77

No elevated caution signal from this screen.

Altman Z-Score

-3.6

Lower score that deserves closer risk review.

FCF / Net Income

57.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Myomo Inc (NYSE-MYO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Myomo Inc (NYSE-MYO)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Myomo Inc (NYSE-MYO). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Myomo Inc (NYSE-MYO) Stock Forecast & Technical Outlook

Review Myomo Inc (NYSE-MYO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Myomo Inc (NYSE-MYO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Myomo Inc (NYSE-MYO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Myomo Inc (NYSE-MYO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Myomo Inc (NYSE-MYO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Myomo Inc (NYSE-MYO) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Myomo Inc (NYSE-MYO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Myomo Inc (NYSE-MYO) has a Strong Buy consensus, with 4 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 0
Sell 0
FAQ • Fast Investor Answers

Myomo Inc (NYSE-MYO) Stock FAQ

Data-supported answers about Myomo Inc (NYSE-MYO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.46
Estimated upside 23.0%
Valuation Rating
Undervalued
Estimated upside of 23.0%
Analyst Target
$4.64
Implied upside 289.9%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Myomo Inc (NYSE-MYO) is $1.46. This implies an estimated upside of 23.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 23.0% versus the current market price.

The available analyst price target for Myomo Inc (NYSE-MYO) is $4.64. The analyst target implies estimated upside of 289.9%.

The current financial health read for Myomo Inc (NYSE-MYO) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Myomo Inc (NYSE-MYO).

The current market capitalization listed for Myomo Inc is 47.133 M.

The current enterprise value listed for Myomo Inc is 53.762 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Myomo Inc is NYSE-MYO, and the stock is listed on NYSE.

Myomo Inc (NYSE-MYO) is listed on NYSE.

The current debt-to-total-capital ratio listed for Myomo Inc is 28.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Myomo Inc is 70.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B